Predicting chemo-radiation response with improved MRI for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial uses a special MRI technique to see if it can predict how well esophageal cancer responds to chemo-radiotherapy before surgery. It may help doctors choose the best treatment plan for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have squamous cell esophageal cancer that is newly diagnosed
- Your cancer is stage cT1b–cT2N+ or cT3–cT4 (any N)
- You have not had chemotherapy or radiation for this cancer before
- You do not have any other type of cancer
- You are able to have an MRI scan safely
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This trial uses CT and MRI scans before and after chemotherapy or radiation to see how well the treatment worked in esophageal cancer. The goal is to match scan results with what doctors find after surgery.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
This study tests a combination of chemotherapy, immunotherapy, and radiation for esophageal cancer that cannot be surgically removed. It also uses a simple blood test (ctDNA) to monitor your cancer's response throughout treatment.
This study looks at whether detailed scans taken before treatment can predict how well chemo and immunotherapy will work for advanced esophageal cancer. The goal is to improve treatment planning and potentially reduce side effects by personalizing care.
This trial uses a special MRI technique (4D FreeBreathing) to see if it can predict how well immune therapy or targeted therapy works for your lung cancer. It may help doctors choose the best treatment for you more quickly.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.